IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 325 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $88,000 | +104.7% | 2,893 | +128.7% | 0.01% | +100.0% |
Q3 2021 | $43,000 | -14.0% | 1,265 | +1.4% | 0.00% | -25.0% |
Q2 2021 | $50,000 | -60.6% | 1,247 | -55.7% | 0.00% | -63.6% |
Q1 2021 | $127,000 | -20.6% | 2,817 | -0.4% | 0.01% | -26.7% |
Q4 2020 | $160,000 | +27.0% | 2,829 | +6.7% | 0.02% | +7.1% |
Q3 2020 | $126,000 | +65.8% | 2,651 | +65.3% | 0.01% | +40.0% |
Q1 2020 | $76,000 | -11.6% | 1,604 | +13.7% | 0.01% | +11.1% |
Q4 2019 | $86,000 | +3.6% | 1,411 | +2.2% | 0.01% | 0.0% |
Q3 2019 | $83,000 | -1.2% | 1,381 | +5.5% | 0.01% | 0.0% |
Q2 2019 | $84,000 | +300.0% | 1,309 | +395.8% | 0.01% | +80.0% |
Q1 2019 | $21,000 | +2000.0% | 264 | +1785.7% | 0.01% | – |
Q3 2018 | $1,000 | 0.0% | 14 | +27.3% | 0.00% | – |
Q3 2017 | $1,000 | -98.9% | 11 | -99.3% | 0.00% | -100.0% |
Q4 2015 | $93,000 | – | 1,516 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |